Breaking News
Top News
-
Stock market today: Dow, S&P 500, Nasdaq futures tread water while crude oil sinks in wait for Iran-US deal update
-
The MacBook Neo Could Be the Best Reason to Buy Apple Stock
-
Intapp (INTA) Fell Over the AI Disruption Narrative
-
Is DraftKings (DKNG) Trading at an Attractive Multiple?
-
Netskope (NTSK) Slid on a Combination of Sector-Wide and Technical Factors
-
Masimo Corporation (MASI) Rose Following the Acquisition Announcement
-
What a $1 Million Dividend Portfolio Actually Pays After Taxes
-
What Makes Dynatrace (DT) a Great Deterministic Data-Oriented Company?
-
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
-
Why Arm Holdings stock is sinking
-
These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again.
-
NanoViricides to Participate at D. Boral Capital Global Conference in NYC
-
US Waits on Iran’s Peace Deal Response as Israel Strikes Lebanon
-
Carlyle Earnings Dip 28% as Carried Interest Remains Elusive
-
Saudi Arabia Sees $10 Billion Lift From Joining Bond Indexes
-
High-Frequency Trader IMC Is Spending Big to Build Team in India
-
Poland Backs Joint EU Debt to Help Finance Defense Spending
-
Moody’s Says South Africa on Track to Stabilize Debt This Year
-
Junk-Bond Craze in Emerging Markets Is Strongest in Eight Years
-
Viridian (VRDN) Climbs 33% on Looming Drug Commercialization
2026-02-05


















